Literature for peptidase S08.044: subtilisin NAT

(References are filtered for relevance to Therapeutic. To remove the filter click here. See explanation.)

2019
1. Wu,H., Wang,H., Xu,F., Chen,J., Duan,L. and Zhang,F.
   Acute toxicity and genotoxicity evaluations of Nattokinase, a promising agent for cardiovascular diseases prevention
   Regul Toxicol Pharmacol103, 205-209. PubMed  Europe PubMed DOI  U
2018
2. Wu,C., Gao,C., Lu,S., Xu,X., Wen,N., Zhang,S. and Liu,M.
   Construction of polylysine dendrimer nanocomposites carrying nattokinase and their application in thrombolysis
   J Biomed Mater Res A106, 440-449. PubMed  Europe PubMed DOI  U
2017
3. Selvarajan,E.
   Nattokinase: an updated critical review on challenges and perspectives
   Cardiovasc Hematol Agents Med Chem PubMed  Europe PubMed DOI  V  U
2015
4. Hitosugi,M., Hamada,K. and Misaka,K.
   Effects of Bacillus subtilis var. natto products on symptoms caused by blood flow disturbance in female patients with lifestyle diseases
   Int J Gen Med8, 41-46. PubMed  Europe PubMed DOI  U
2014
5. Xu,J., Du,M., Yang,X., Chen,Q., Chen,H. and Lin,D.H.
   Thrombolytic effects in vivo of nattokinase in a carrageenan-induced rat model of thrombosis
   Acta Haematol132, 247-253. PubMed  Europe PubMed DOI  U
2009
6. Hsu,R.L., Lee,K.T., Wang,J.H., Lee,L.Y. and Chen,R.P.
   Amyloid-degrading ability of nattokinase from Bacillus subtilis Natto
   J Agric Food Chem57, 503-508. PubMed  Europe PubMed DOI  U